We are pleased to advise that the Paxil class action against GlaxoSmithKline with respect to cardiovascular birth defects caused by Paxil has been settled. The settlement approval hearing will be conducted by Mr. Justice Smith on March 27, 2017 in the British Columbia Supreme Court.